These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8974063

  • 1. Chronic low-dose treatment with enalapril induced cardiac regression of left ventricular hypertrophy.
    Makino N, Sugano M, Hata T, Taguchi S, Yanaga T.
    Mol Cell Biochem; 1996; 163-164():239-45. PubMed ID: 8974063
    [Abstract] [Full Text] [Related]

  • 2. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R, Young SD, Strosberg AM.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
    Magga J, Kalliovalkama J, Romppanen H, Vuolteenaho O, Pörsti I, Kähönen M, Tolvanen JP, Ruskoaho H.
    J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential suppression of pressure-overload cardiac and aortic hypertrophy in rats by angiotensin-converting enzyme inhibitors.
    Wang DQ, Kakizoe E, Kobayashi Y, Shimoura K, Okunishi H.
    Jpn J Pharmacol; 1999 Aug; 80(4):333-42. PubMed ID: 10496334
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
    Tokioka-Akagi T, Fujimori A, Shibasaki M, Inagaki O, Yanagisawa I.
    Jpn J Pharmacol; 2001 May; 86(1):79-85. PubMed ID: 11430476
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative effects of type 1 angiotensin II-receptor blockade with angiotensin-converting-enzyme inhibitor on left ventricular distensibility and collagen metabolism in spontaneously hypertensive rats.
    Yonezawa T, Umemoto S, Fujii A, Katayama K, Matsuzaki M.
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):119-24. PubMed ID: 8656644
    [Abstract] [Full Text] [Related]

  • 9. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
    Lear W, Ruzicka M, Leenen FH.
    Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479
    [Abstract] [Full Text] [Related]

  • 10. Alteration of cardiac ACE2/Mas expression and cardiac remodelling in rats with aortic constriction.
    Zhang Y, Li B, Wang B, Zhang J, Wu J, Morgan T.
    Chin J Physiol; 2014 Dec 31; 57(6):335-42. PubMed ID: 25575522
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 12. Modulation of adrenergic receptors during regression of cardiac hypertrophy.
    Matsui H, Makino N, Yano K, Nakanishi H, Hata T, Yanaga T.
    J Hypertens; 1994 Dec 15; 12(12):1353-7. PubMed ID: 7706693
    [Abstract] [Full Text] [Related]

  • 13. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
    Raasch W, Bartels T, Schwartz C, Häuser W, Rütten H, Dominiak P.
    J Hypertens; 2002 Dec 15; 20(12):2495-504. PubMed ID: 12473875
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y.
    Hypertension; 1998 Sep 15; 32(3):467-72. PubMed ID: 9740612
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
    Chiba K, Moriyama S, Ishigai Y, Fukuzawa A, Irie K, Shibano T.
    Br J Pharmacol; 1994 Jul 15; 112(3):837-42. PubMed ID: 7921610
    [Abstract] [Full Text] [Related]

  • 18. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
    Huang W, Alhenc Gelas F, Osborne-Pellegrin MJ.
    Circ Res; 1998 May 04; 82(8):879-90. PubMed ID: 9576107
    [Abstract] [Full Text] [Related]

  • 19. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
    Taylor K, Patten RD, Smith JJ, Aronovitz MJ, Wight J, Salomon RN, Konstam MA.
    J Cardiovasc Pharmacol; 1998 May 04; 31(5):654-60. PubMed ID: 9593063
    [Abstract] [Full Text] [Related]

  • 20. Protective action of angiotensin converting enzyme inhibitors on cardiac hypertrophy in the aortic-banded rat.
    Kurosawa Y, Kojima K, Kato M, Ohashi R, Minami K, Narita H.
    Jpn Heart J; 1999 Sep 04; 40(5):645-54. PubMed ID: 10888384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.